By proceeding, you agree to our Terms of Use and Privacy Policy.
Executive Director Process Development, Drug Substance Technologies Pivotal & Commercial Synthetics
#amgen #mycompany #amgenchemistry #equalopportunities #processdevelopment
#NorthAmerica
Oliver Thiel is Executive Director Process Development, Drug Substance Technologies Pivotal & Commercial Synthetics at Amgen.